Results 251 to 260 of about 111,950 (304)
Evolutionary constraint helps unmask a splicing regulatory region in BRCA1 exon 11
Baralle, D. +4 more
core +1 more source
BRCA1/2-stratified immune profiling of treatment-naive high-grade serous ovarian cancer ascites identifies a Treg-enriched ascitic immune phenotype. [PDF]
Sharma M +8 more
europepmc +1 more source
Conversational AI in Hereditary Cancer Care: Sociotechnical Study of Responsible Design Requirements. [PDF]
Lammert D +8 more
europepmc +1 more source
Monoallelic BRCA1/2 variants in pediatric, adolescent, and young adult patients with central nervous system tumors. [PDF]
Cipri S +10 more
europepmc +1 more source
Cost-effectiveness of BRCA1/BRCA2 variant reclassification and recontact for hereditary breast and ovarian cancer in the United States. [PDF]
Guzauskas GF +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Mutation Research/Reviews in Mutation Research, 2002
Breast cancer is one of the most frequent malignancies affecting women. The human breast cancer gene 1 (BRCA1) gene is mutated in a distinct proportion of hereditary breast and ovarian cancers. Tumourigenesis in individuals with germline BRCA1 mutations requires somatic inactivation of the remaining wild-type allelle. Although, this evidence supports a
Marion, Kubista +7 more
openaire +2 more sources
Breast cancer is one of the most frequent malignancies affecting women. The human breast cancer gene 1 (BRCA1) gene is mutated in a distinct proportion of hereditary breast and ovarian cancers. Tumourigenesis in individuals with germline BRCA1 mutations requires somatic inactivation of the remaining wild-type allelle. Although, this evidence supports a
Marion, Kubista +7 more
openaire +2 more sources

